Celularity Financial Statements From 2010 to 2024

CELUW Stock  USD 0.02  0.0006  3.97%   
Celularity financial statements provide useful quarterly and yearly information to potential Celularity investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Celularity financial statements helps investors assess Celularity's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Celularity's valuation are summarized below:
Quarterly Earnings Growth
(0.61)
Profit Margin
(2.64)
Revenue
42.7 M
Earnings Share
(0.87)
Quarterly Revenue Growth
3.122
There are over one hundred nineteen available fundamental signals for Celularity, which can be analyzed over time and compared to other ratios. All traders should should validate Celularity's prevailing fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Market Cap is likely to drop to about 41.8 M in 2024. Enterprise Value is likely to drop to about 103.7 M in 2024

Celularity Total Revenue

21.45 Million

Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.6 M, Interest Expense of 2.5 M or Selling General Administrative of 48.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Celularity Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets136.7 M143.9 M121.3 M
Slightly volatile
Short and Long Term Debt Total79.2 M75.4 M20.8 M
Slightly volatile
Total Current Liabilities70.7 M67.3 M17 M
Slightly volatile
Cash215.7 K227 K7.1 M
Slightly volatile
Non Current Assets Total117.9 M124.1 M109.1 M
Slightly volatile
Cash And Short Term Investments23.4 M16.1 M9.7 M
Slightly volatile
Liabilities And Stockholders Equity338.4 M461.2 M155.9 M
Slightly volatile
Other Stockholder EquityB971 M259.3 M
Slightly volatile
Total Liabilities97.8 M102.9 M114 M
Slightly volatile
Total Current Assets30 M19.8 M12.9 M
Slightly volatile
Common Stock12.8 K13.5 K17.2 M
Pretty Stable
Net Tangible Assets197.9 M192.7 M255.9 M
Slightly volatile
Property Plant And Equipment Net91.2 M78.8 M73.6 M
Slightly volatile
Warrants193.9 M188.2 M251 M
Slightly volatile
Accounts Payable8.4 M14.1 M5.3 M
Slightly volatile
Net ReceivablesM10 M4.4 M
Slightly volatile
Good WillM7.3 M110.1 M
Slightly volatile
Common Stock Total Equity329.6 M313.9 M97.5 M
Slightly volatile
Common Stock Shares Outstanding11.8 M19.4 M6.4 M
Slightly volatile
Non Current Liabilities Total33.8 M35.6 M114.2 M
Slightly volatile
Capital Surpluse28 M55.6 M16.9 M
Slightly volatile
Inventory6.1 M5.8 M4.2 M
Slightly volatile
Other Current Assets312.6 K329 K1.1 M
Slightly volatile
Non Current Liabilities Other1.8 M1.9 M35 M
Slightly volatile
Intangible Assets10.5 M11 M207 M
Slightly volatile
Current Deferred Revenue2.5 MM4.1 M
Slightly volatile
Short Term Investments233.4 M262.6 M286 M
Slightly volatile
Capital Lease Obligations23.2 M26.2 M29.7 M
Slightly volatile
Deferred Long Term Liabilities482542590
Slightly volatile
Property Plant And Equipment Gross114.9 M106.1 M100.3 M
Slightly volatile
Capital Stock12.9 K19 K4.7 K
Slightly volatile
Short Term Debt45.4 M43.2 M10.8 M
Slightly volatile
Short and Long Term Debt42.3 M39.2 M38 M
Slightly volatile

Celularity Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization20.6 M10.8 M10.8 M
Slightly volatile
Interest Expense2.5 MM3.4 M
Slightly volatile
Selling General Administrative48.1 M50.6 M18.1 M
Slightly volatile
Selling And Marketing Expenses139.4 K146.7 K869.7 K
Slightly volatile
Total Revenue21.5 M22.8 M20.6 M
Pretty Stable
Other Operating Expenses118.2 M191.2 M50.3 M
Slightly volatile
Research Development47.4 M30.5 M50.5 M
Slightly volatile
Cost Of Revenue12.4 M16 M8.4 M
Slightly volatile
Total Operating Expenses108.8 M99.2 M41.2 M
Slightly volatile
Interest Income277.4 K320 K357.6 K
Slightly volatile
Reconciled Depreciation9.8 M9.3 M8.5 M
Slightly volatile

Celularity Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation17.4 M15 M8.6 M
Slightly volatile
Begin Period Cash Flow42.7 M28.8 M15.8 M
Slightly volatile
Depreciation9.2 M9.3 M7.1 M
Slightly volatile
Capital Expenditures3.8 MM24.2 M
Slightly volatile
Total Cash From Financing Activities22.9 M24.1 M217.1 M
Slightly volatile
End Period Cash Flow9.7 M10.2 M12 M
Slightly volatile
Other Cashflows From Investing Activities752 K823.6 K682.3 K
Slightly volatile
Change To Netincome56.3 M53.6 M16.7 M
Slightly volatile
Change To Liabilities1.9 M3.7 M1.2 M
Slightly volatile
Issuance Of Capital Stock20.8 M21.9 M86 M
Slightly volatile
Dividends Paid31.3 M35.2 M38.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.841.9322129
Slightly volatile
Days Sales Outstanding108194107
Slightly volatile
Average Payables2.1 M2.4 M2.6 M
Slightly volatile
Stock Based Compensation To Revenue0.550.65950.4503
Slightly volatile
Capex To Depreciation0.410.43410.9477
Pretty Stable
EV To Sales4.564.795129
Slightly volatile
Inventory Turnover1.682.78391.9401
Pretty Stable
Days Of Inventory On Hand231131204
Very volatile
Payables Turnover1.081.132423.5768
Pretty Stable
Sales General And Administrative To Revenue1.822.21910.8962
Slightly volatile
Research And Ddevelopement To Revenue2.311.33792.1946
Slightly volatile
Capex To Revenue0.170.17780.357
Slightly volatile
Cash Per Share0.01210.01270.6803
Slightly volatile
Days Payables Outstanding197322268
Pretty Stable
Intangibles To Total Assets0.120.127512.7 K
Slightly volatile
Current Ratio0.280.29410.7414
Slightly volatile
Receivables Turnover3.341.87913.7699
Slightly volatile
Graham Number22.6823.87823.3678
Slightly volatile
Debt To Equity1.010.9580.295
Slightly volatile
Capex Per Share0.220.22731.2009
Pretty Stable
Revenue Per Share1.211.27841.3434
Pretty Stable
Interest Debt Per Share2.492.37220.688
Slightly volatile
Debt To Assets0.140.27270.1088
Slightly volatile
Operating Cycle258325295
Pretty Stable
Days Of Payables Outstanding197322268
Pretty Stable
Total Debt To Capitalization0.260.48930.1877
Slightly volatile
Debt Equity Ratio1.010.9580.295
Slightly volatile
Net Income Per E B T0.781.00010.9158
Pretty Stable
Cash Ratio0.00320.00340.6111
Pretty Stable
Days Of Inventory Outstanding231131204
Very volatile
Days Of Sales Outstanding108194107
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.051.10462.1 K
Slightly volatile
Fixed Asset Turnover0.270.28892.7241
Slightly volatile
Debt Ratio0.140.27270.1088
Slightly volatile
Price Sales Ratio1.841.9322129
Slightly volatile
Asset Turnover0.150.1583426
Slightly volatile

Celularity Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap41.8 M44 M262.6 M
Very volatile
Enterprise Value103.7 M109.2 M291.8 M
Very volatile

About Celularity Financial Statements

Celularity investors use historical fundamental indicators, such as Celularity's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Celularity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred RevenueM2.5 M
Total Revenue22.8 M21.5 M
Cost Of Revenue16 M12.4 M
Stock Based Compensation To Revenue 0.66  0.55 
Sales General And Administrative To Revenue 2.22  1.82 
Research And Ddevelopement To Revenue 1.34  2.31 
Capex To Revenue 0.18  0.17 
Revenue Per Share 1.28  1.21 
Ebit Per Revenue(8.44)(8.02)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.